Nevro Announces New CEO, Board Appointments and Agreement with Broadfin Capital

Go back to Nevro Announces New CEO, Board Appointments and Agreement with Broadfin Capital

Morgan Stanley Upgrades Nevro Corp (NVRO) Two-Notches to Overweight; Positive on New Platform

March 21, 2019 7:19 AM EDT

Morgan Stanley analyst David Lewis upgraded Nevro Corp (NYSE: NVRO) from Underweight to Overweight with a price target of $70.00 (from $41.00). The analyst cited:

Nevro's new platform launch addresses concerns we had about Senza differentiation versus multi-modality systems and should lead to market share... More